Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Takayuki Kifuji"'
Autor:
Rie Tsubota, Taku Iguchi, Takehisa Kawata, Naoya Sato, Takayuki Kifuji, Osamu Sakurai, Tetsuya Sakairi, Hiroshi Miyazaki, Rikiya Ohashi, Hikaru Yoneda, Koki Kojima, Yousuke Ikeda, Tsutomu Miyake, Yasunori Moritani, Yukihito Tsukumo, Hajime Fukuda, Ayako Kannami, Shin Tokunaga, Tetsuya Yanagida, Jyunko Okabe, Yutaka Hisada, Akiko Idei, Masataka Kuroda
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:2055-2060
The calcium-sensing receptor (CaSR) plays an important role in sensing extracellular calcium ions and regulating parathyroid hormone secretion by parathyroid gland cells, and the receptor is a suitable target for the treatment of hyperparathyroidism.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38595c9fa253c9741813c46283641921
https://doi.org/10.1016/j.bmcl.2018.04.055
https://doi.org/10.1016/j.bmcl.2018.04.055
Autor:
Megumi Furukawa, Shinsuke Inoue, Stuart Mair, Takahiro Goto, Atsuhiro Kawaguchi, Takayuki Kifuji, Hiroshi Kumagai, Begonya Perez Madera
The absorption, metabolism and excretion of MT-1303 were investigated in healthy male subjects after a single oral dose of 0.4 mg [14C]-MT-1303 (ClinicalTrials.gov NCT02293967).The MT-1303 concentration in the plasma reached a maximum at 12 h after a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bca2e5a22160e4aec937dc4fc54ddf8
Publikováno v:
Advances in Therapy
Introduction Canagliflozin is a sodium glucose co-transporter 2 inhibitor approved worldwide for the treatment of patients with type 2 diabetes mellitus (T2DM). The present study evaluated pharmacokinetics, pharmacodynamics, and safety of canaglifloz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a82cf3991b17be474fbb169d242603
https://pubmed.ncbi.nlm.nih.gov/26280756
https://pubmed.ncbi.nlm.nih.gov/26280756